Minapharm Pharmaceuticals (CAI:MIPH) FCF Margin % : 0.00% (As of Dec. 2022)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Minapharm Pharmaceuticals's Free Cash Flow for the three months ended in Dec. 2022 was E£0 Mil. Minapharm Pharmaceuticals's Revenue for the three months ended in Dec. 2022 was E£0 Mil. Therefore, Minapharm Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2022 was 0.00%.

As of today, Minapharm Pharmaceuticals's current FCF Yield % is -55.21%.

The historical rank and industry rank for Minapharm Pharmaceuticals's FCF Margin % or its related term are showing as below:

CAI:MIPH' s FCF Margin % Range Over the Past 10 Years
Min: -33.48 Med: -25.04 Max: -16.59
Current: -33.48

During the past 2 years, the highest FCF Margin % of Minapharm Pharmaceuticals was -16.59%. The lowest was -33.48%. And the median was -25.04%.

CAI:MIPH's FCF Margin % is ranked worse than
81.78% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 0.25 vs CAI:MIPH: -33.48

Minapharm Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Minapharm Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals FCF Margin % Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

FCF Margin %

-16.59

-33.48

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Dec23
FCF Margin %	-	-

Competitive Comparison of Minapharm Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minapharm Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's FCF Margin % falls into.

Minapharm Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Minapharm Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1303.088	/	3892.05
	=	-33.48 %

Minapharm Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2022 )	/	Revenue (Q: Dec. 2022 )
	=	0	/	0
	=	%

Minapharm Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals (CAI:MIPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

http://www.minapharm.com

Minapharm Pharmaceuticals produces prescription drugs in Egypt and the Middle East. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals (CAI:MIPH) Headlines

No Headlines